BALTIMORE — BC3 Technologies, a privately held medical device company, today announced that its SEAL Hemostatic Spray – the first and only aerosolized chitosan for management of serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback